PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study of LRRK2 (Leucine-rich Repeat Kinase 2) — PROGENI  

Parkinson Disease Clinical Trial

Official title: PROGENI (Parkinson's Research: The Organized Genetics Initiative) Family Study

Status Completed

Clinical Trial Summary

The PROGENI Family Study is part of a larger consortium that is studying a gene shown to be important in Parkinson's disease, called LRRK2. People who have a defect in the LRRK2 gene will often develop Parkinson's disease. Eligible participants will be asked to complete a single Study Visit at an affiliated research facility closest to their home.

Clinical Trial Description

Participants will be asked to complete a family history questionnaire, which will gather information about their family history of Parkinson's disease and related disorders. They will be asked to complete a single Study Visit, during which they will be asked to do some or all of the following:

1. Complete questionnaires regarding Parkinson's disease symptoms, medical history, mood, sleep, mental status, and activity level.

2. Be given a brief standard neurological examination.

3. Be given a scratch and sniff smell identification test.

4. Be asked to give a sample of approximately 2 tablespoons of blood.

5. Be asked to give a urine sample of approximately 1 tablespoon of urine. ;

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Parkinson Disease

• NCT number: NCT01536821
• Study type: Observational
• Source: Indiana University
• Status: Completed
• Phase: N/A
• Start date: May 2011
• Completion date: December 2013